ID
33406
Description
Study ID: 106837 Clinical Study ID: HZA106837 Study Title: A Long-Term, Randomized, Double-Blind, Parallel Group Study of Fluticasone Furoate/GW642444 Inhalation Powder Once-Daily and Fluticasone Furoate Inhalation Powder Once-Daily in Subjects with Asthma Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01086384 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone furoate/vilanterol Trade Name: Relvar Study Indication: Asthma
Keywords
Versions (2)
- 11/6/18 11/6/18 -
- 12/7/18 12/7/18 -
Copyright Holder
GSK group of companies
Uploaded on
December 7, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
A Parallel Group Study of Fluticasone Furoate/Vilanterol in Subjects with Asthma - 106837
Pharmacokinetics (Liver PK)
- StudyEvent: ODM
Similar models
Pharmacokinetics (Liver PK)
- StudyEvent: ODM
C0370003 (UMLS CUI-2)
C0370003 (UMLS CUI [1,2])
C0370003 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0370003 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,3])
C1762893 (UMLS CUI [1,2])
C0201734 (UMLS CUI [2,1])
C0370003 (UMLS CUI [2,2])
C0946444 (UMLS CUI [1,2])